Journal of Dermatology and Dermatologic Diseases

Shital Poojary

Publications

• Review Article
  Tranexamic Acid in Melasma: A Review
  Author(s): Shital Poojary and Khushboo MinniShital Poojary and Khushboo Minni
  
  Melasma is a localized, chronic acquired hypermelanosis of the skin. Despite several treatments available, melasma can often be refractory to treatment. Also recurrences are common. Tranexamic acid is a new addition in treatment of melasma and is effective in dosage of 250 mg BD for atleast 4 to 8 weeks. Tranexamic acid acts mainly via the plasminogen activator-plasmin system to prevent UV radiation induced pigmentation in melasma. This article reviews the mechanism of action of tranexamic acid in melasma and current evidence in literature for use of tranexamic acid in melasma. .. Read More»
  DOI: 10.4172/2376-0427.1000228

  Abstract PDF